Sarah Crain, MS, DACVIM (SAIM), PhD CandidateDepartment of Clinical Sciences

Dr. Sarah Crain

    Sarah Crain, MS, DACVIM (SAIM), PhD Candidate : She is examining the role of extracellular vesicles in immunomodulation by canine fetal (placental, umbilical cord matrix) mesenchymal stem cells. She is also conducting a dose-escalation clinical trial of allogeneic umbilical cord matrix (Wharton’ Jelly) derived mesenchymal stem cells for treatment of naturally occurring, refractory inflammatory bowel disease with protein-losing enteropathy (PLE) in dogs.

    View Dr. Crain’s full profile.

    Stem cells derived from one puppy’s extra-embryonic tissues. A) Chorioallantoic-derived, B) Amnion-derived, and C) Wharton’s Jelly-derived.

    Stem cells derived from one puppy’s extra-embryonic tissues. A) Chorioallantoic-derived, B) Amnion-derived, and C) Wharton’s Jelly-derived.

    Regenerative Medicine Laboratory © 2017 Cummings School of Veterinary Medicine at Tufts University - Privacy